Suchergebnisse - "Roy Moulik, Nirmalya"

PubPharm (38)

1

Challenges in Management of Pediatric Chronic Myeloid Leukemia (pCML) in the Low-Middle Income Countries (LMICs) : Insights from an International CML Foundation (iCMLf) Multi-National Survey

enthalten in: Pediatric hematology and oncology | 2024

von Roy Moulik, N. | Harriss-Buchan, A. | Saglio, G. | +1

2

Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort

enthalten in: British journal of haematology | 2024

von Roy Moulik, N. | Keerthivasagam, S. | Pandey, A. | +15

3

Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid Malignancies

enthalten in: JCO global oncology | 2024

von Sharma, S. | Dhamne, C. | Bhosale, S. | +17

4

Clinico-radiological profile, management and follow-up of methotrexate induced neurotoxicity in children with acute lymphoblastic leukemia

enthalten in: Leukemia & lymphoma | 2023

von Dhariwal, N. | Roy Moulik, N. | Smriti, V. | +5

5

Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, India

enthalten in: Annals of hematology | 2023

von Roy Moulik, N. | Keerthivasagam, S. | Velagala, S. | +13

6

Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India

enthalten in: Annals of hematology | 2023

von Roy Moulik, N. | Keerthivasagam, S. | Velagala, S. | +13

7

Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India

enthalten in: Annals of hematology | 2023

von Roy Moulik, N. | Keerthivasagam, S. | Velagala, S. | +13

8

Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India

enthalten in: Annals of hematology | 2023

von Roy Moulik, N. | Keerthivasagam, S. | Velagala, S. | +13

9

Comment on : Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia

enthalten in: Pediatric blood & cancer | 2023

von Srinivasan, S. | Roy Moulik, N. | Dhamne, C.

CommentOn: Pediatr Blood Cancer. 2022 Aug;69(8):e29715. - PMID 35482538

10

Intracranial disease in pediatric Hodgkin lymphoma-case report and review of literature

enthalten in: American journal of blood research | 2023

von Dhariwal, N. | Roy Moulik, N. | Bhat, V. | +9